Precision medicine approach for pain control
Precision Medicine for Sng/Pain Control
NA · National Taiwan University Hospital · NCT05154695
This study is testing whether understanding your genes can help doctors find the best pain treatments for people with myofascial pain syndrome.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 88 (estimated) |
| Ages | 20 Years to 100 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital (other) |
| Locations | 1 site (Taipei) |
| Trial ID | NCT05154695 on ClinicalTrials.gov |
What this trial studies
This study aims to identify genetic markers that influence patient responses to various pain treatment modalities, including low-level laser therapy, ultrasound, and prolotherapy. By analyzing blood and urine samples from patients with myofascial pain syndrome, researchers will explore the relationship between genetic variants and treatment efficacy. The goal is to develop a precision medicine algorithm that tailors pain management strategies based on individual genetic profiles. The study will recruit 80 patients from the National Taiwan University Hospital Bei-Hu Branch over two years.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 20-100 diagnosed with myofascial pain syndrome who are willing to undergo the specified treatments.
Not a fit: Patients with active infections, malignancies, hematological diseases, or those who have received local injections in the past three months may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and personalized pain management strategies for patients.
How similar studies have performed: While the approach of using genetic markers for treatment personalization is gaining traction, this specific study's methodology is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) Age between 20-100 years old. * (2) Diagnosed as myofascial pain syndrome patients and willing to receive treatment (including LLLT, therapeutic ultrasound, and local dextrose injection therapy). Exclusion Criteria: * Those having active infection, malignancy, and hematological diseases were excluded. The patients had received local injection at upper trapezius within 3 months are also excluded.
Where this trial is running
Taipei
- National Taiwan University Hospital Bei-Hu Branch — Taipei, Taiwan (RECRUITING)
Study contacts
- Study coordinator: Der-Sheng Han, Physician
- Email: dshan1121@yahoo.com.tw
- Phone: 0972-653-916
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Rehabilitation, Pain, Shoulder, Pain, Chronic, sng/pain, Low-level Laser Therapy, ultrasound, prolotherapy, next generation sequencing